Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib maintenance versus observation after chemotherapy in advanced non-small cell lung cancer
2004-001331-36Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gefitinib in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Started Feb 2005; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2004-001331-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001331-36.